Calin Mihaela Antonina, Gruia Maria Iuliana, Herascu Nicoleta, Coman Toma
National Institute for Optoelectronics, Bucharest, Romania.
Photomed Laser Surg. 2005 Aug;23(4):405-9. doi: 10.1089/pho.2005.23.405.
Photodynamic therapy of Walker tumor after subcutaneous administration of 5-ALA solution using a multiple laser irradiation scheme was monitored by the fluorescence imaging technique to investigate the effectiveness of 5-ALA-PDT.
Photodynamic therapy (PDT) is a localized cancer treatment based on the selective uptake and retention of photosensitizer at the tumoral level and on the activation of the photosensitizer by a specific wavelength of light, aiming to induce cytotoxic reactions. As a new photosensitizer, the heme precursor 5- aminolevulinic acid has been introduced recently for photodynamic therapy of tumors and precancerous lesions of the skin. It has been shown that the efficacy of topical 5-ALA-PDT is limited for deeper skin tumor by the depth of 5-ALA penetration through the skin. Oral or systemic administration of ALA or the use of different irradiation schemes may improve tumor response to PDT.
Laser irradiation parameters used in this study were lambda = 635 nm, P = 3 mW, t(exp) = 300 sec, and three sessions. The fluorescence was excitated by monochromatic light of 405 nm. The temporal behavior of PpIX fluorescence was studied by processing and analyzing the fluorescence images acquired just after applying 5-ALA, just before and just after three laser irradiations.
The results demonstrate that PpIX is highly selective for tumors areas and a re-accumulation of PpIX appears between laser irradiations. During laser irradiation, the PpIX fluorescence intensity decreases rapidly, reflecting the photodegradation of PpIX.
In conclusion, the use of a multiple laser irradiation scheme, for the activation of reaccumulation of Pp IX (with three steps) is effective for photodynamic therapy of Walker tumor.
采用多激光照射方案,通过荧光成像技术监测皮下注射5-氨基乙酰丙酸(5-ALA)溶液后对Walker肿瘤进行光动力治疗的效果,以研究5-ALA光动力疗法(5-ALA-PDT)的有效性。
光动力疗法(PDT)是一种局部癌症治疗方法,基于肿瘤水平对光敏剂的选择性摄取和保留,以及特定波长光对光敏剂的激活,旨在诱导细胞毒性反应。作为一种新型光敏剂,血红素前体5-氨基乙酰丙酸最近已被引入用于皮肤肿瘤和癌前病变的光动力治疗。已表明,由于5-ALA穿透皮肤的深度,局部5-ALA-PDT对较深皮肤肿瘤的疗效有限。口服或全身给予ALA或使用不同的照射方案可能会改善肿瘤对PDT的反应。
本研究中使用的激光照射参数为:波长λ=635nm,功率P = 3mW,曝光时间t(exp)=300秒,共三个疗程。荧光由405nm单色光激发。通过处理和分析在应用5-ALA后、三次激光照射前及照射后立即采集的荧光图像,研究原卟啉IX(PpIX)荧光的时间行为。
结果表明,PpIX对肿瘤区域具有高度选择性,并且在激光照射之间出现PpIX的重新积累。在激光照射期间,PpIX荧光强度迅速降低,反映了PpIX的光降解。
总之,使用多激光照射方案(分三步激活PpIX的重新积累)对Walker肿瘤进行光动力治疗是有效的。